PL375254A1 - PEG-ilowany polipeptyd T20 - Google Patents
PEG-ilowany polipeptyd T20Info
- Publication number
- PL375254A1 PL375254A1 PL03375254A PL37525403A PL375254A1 PL 375254 A1 PL375254 A1 PL 375254A1 PL 03375254 A PL03375254 A PL 03375254A PL 37525403 A PL37525403 A PL 37525403A PL 375254 A1 PL375254 A1 PL 375254A1
- Authority
- PL
- Poland
- Prior art keywords
- pegylated
- polypeptide
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
- C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
- C07K14/16—HIV-1 ; HIV-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39819502P | 2002-07-24 | 2002-07-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL375254A1 true PL375254A1 (pl) | 2005-11-28 |
Family
ID=31495720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03375254A PL375254A1 (pl) | 2002-07-24 | 2003-07-16 | PEG-ilowany polipeptyd T20 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7049415B2 (pl) |
| EP (1) | EP1527088B1 (pl) |
| JP (1) | JP4381301B2 (pl) |
| KR (1) | KR100637981B1 (pl) |
| CN (1) | CN100357317C (pl) |
| AR (1) | AR040651A1 (pl) |
| AT (1) | ATE489401T1 (pl) |
| AU (1) | AU2003257467B2 (pl) |
| BR (1) | BR0312889A (pl) |
| CA (1) | CA2493534C (pl) |
| DE (1) | DE60335111D1 (pl) |
| ES (1) | ES2354609T3 (pl) |
| GT (1) | GT200300155A (pl) |
| HR (1) | HRP20050024A2 (pl) |
| IL (2) | IL166038A0 (pl) |
| MX (1) | MXPA05000797A (pl) |
| NO (1) | NO20050066L (pl) |
| PA (1) | PA8577701A1 (pl) |
| PE (1) | PE20040705A1 (pl) |
| PL (1) | PL375254A1 (pl) |
| RU (1) | RU2296769C2 (pl) |
| TW (1) | TW200416225A (pl) |
| WO (1) | WO2004013164A1 (pl) |
| ZA (1) | ZA200500258B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| EP2311432B1 (en) | 2002-06-07 | 2014-12-24 | Dyax Corporation | Modified kunitz domain polypeptides and their use for reducing ischemia or the onset of a systemic inflammatory response associated with a surgical procedure |
| US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
| JP2007504169A (ja) * | 2003-08-29 | 2007-03-01 | ダイアックス コーポレーション | 修飾されたプロテアーゼインヒビター |
| ES2447423T3 (es) * | 2003-08-29 | 2014-03-12 | Dyax Corp. | Inhibidores de proteasa poli-pegilados |
| KR101276422B1 (ko) * | 2004-03-15 | 2013-06-19 | 넥타르 테라퓨틱스 | Ｈｉｖ 유입 억제제의 중합체-기재 조성물 및 콘쥬게이트 |
| US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| JP2008534639A (ja) * | 2005-04-08 | 2008-08-28 | ロンザ ア−ゲ− | Ｐｅｇ樹脂上におけるアルファ−ヘリックスのペプチド合成 |
| WO2009026334A2 (en) * | 2007-08-21 | 2009-02-26 | Genzyme Corporation | Treatment with kallikrein inhibitors |
| JP2013516389A (ja) | 2009-01-06 | 2013-05-13 | ダイアックス コーポレーション | カリクレイン阻害剤による粘膜炎治療 |
| EP3459564B1 (en) | 2010-01-06 | 2021-10-27 | Takeda Pharmaceutical Company Limited | Plasma kallikrein binding proteins |
| JP2014506257A (ja) | 2011-01-06 | 2014-03-13 | ダイアックス コーポレーション | 血漿カリクレイン結合タンパク質 |
| AU2015235967B2 (en) | 2014-03-27 | 2020-10-22 | Takeda Pharmaceutical Company Limited | Compositions and methods for treatment of diabetic macular edema |
| US10046058B2 (en) | 2014-12-02 | 2018-08-14 | Rezolute, Inc. | Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates |
| JP7003354B2 (ja) | 2015-12-11 | 2022-03-04 | 武田薬品工業株式会社 | 遺伝性血管性浮腫の発作を治療するための血漿カリクレイン阻害薬およびその用途 |
| JP2023510854A (ja) | 2020-01-13 | 2023-03-15 | 武田薬品工業株式会社 | 小児遺伝性血管性浮腫発作を治療するための血漿カリクレイン阻害剤及びその使用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US153694A (en) * | 1874-08-04 | Improvement in clothes-pounders | ||
| KR850004274A (ko) | 1983-12-13 | 1985-07-11 | 원본미기재 | 에리트로포이에틴의 제조방법 |
| US5252714A (en) | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
| US5464933A (en) * | 1993-06-07 | 1995-11-07 | Duke University | Synthetic peptide inhibitors of HIV transmission |
| US5795569A (en) * | 1994-03-31 | 1998-08-18 | Amgen Inc. | Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation |
| CH690143A5 (de) | 1995-01-27 | 2000-05-15 | Rieter Automotive Int Ag | Lambda/4-Schallabsorber. |
| US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| US5990237A (en) | 1997-05-21 | 1999-11-23 | Shearwater Polymers, Inc. | Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines |
| US6281331B1 (en) | 1998-03-23 | 2001-08-28 | Trimeris, Inc. | Methods and compositions for peptide synthesis |
| WO1999048513A1 (en) * | 1998-03-23 | 1999-09-30 | Trimeris, Inc. | Methods and compositions for peptide synthesis |
| US6465694B1 (en) | 1998-10-26 | 2002-10-15 | University Of Utah Research Foundation | Method for preparation of polyethylene glycol aldehyde derivatives |
| CA2352538A1 (en) * | 1998-11-30 | 2000-06-08 | Eli Lilly And Company | Erythropoietic compounds |
| PE20010288A1 (es) * | 1999-07-02 | 2001-03-07 | Hoffmann La Roche | Derivados de eritropoyetina |
| RU2179980C2 (ru) * | 2000-03-20 | 2002-02-27 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Пептид-имитатор консервативного эпитопа белка gp41 вируса иммунодефицита человека типа 1, узнаваемого вируснейтрализующими моноклональными антителами 2f5 (варианты) |
| KR100488351B1 (ko) | 2001-12-11 | 2005-05-11 | 선바이오(주) | 신규한 폴리에틸렌글리콜-프로피온알데히드 유도체 |
-
2003
- 2003-07-16 MX MXPA05000797A patent/MXPA05000797A/es active IP Right Grant
- 2003-07-16 HR HR20050024A patent/HRP20050024A2/xx not_active Application Discontinuation
- 2003-07-16 CN CNB038176807A patent/CN100357317C/zh not_active Expired - Fee Related
- 2003-07-16 PL PL03375254A patent/PL375254A1/pl not_active Application Discontinuation
- 2003-07-16 AT AT03766190T patent/ATE489401T1/de active
- 2003-07-16 RU RU2005105577/04A patent/RU2296769C2/ru not_active IP Right Cessation
- 2003-07-16 EP EP03766190A patent/EP1527088B1/en not_active Expired - Lifetime
- 2003-07-16 IL IL16603803A patent/IL166038A0/xx unknown
- 2003-07-16 BR BR0312889-0A patent/BR0312889A/pt not_active IP Right Cessation
- 2003-07-16 ES ES03766190T patent/ES2354609T3/es not_active Expired - Lifetime
- 2003-07-16 KR KR1020057001217A patent/KR100637981B1/ko not_active Expired - Fee Related
- 2003-07-16 WO PCT/EP2003/007710 patent/WO2004013164A1/en not_active Ceased
- 2003-07-16 CA CA2493534A patent/CA2493534C/en not_active Expired - Fee Related
- 2003-07-16 DE DE60335111T patent/DE60335111D1/de not_active Expired - Lifetime
- 2003-07-16 JP JP2004525219A patent/JP4381301B2/ja not_active Expired - Fee Related
- 2003-07-16 AU AU2003257467A patent/AU2003257467B2/en not_active Ceased
- 2003-07-18 TW TW092119716A patent/TW200416225A/zh unknown
- 2003-07-21 US US10/623,873 patent/US7049415B2/en not_active Expired - Fee Related
- 2003-07-21 PA PA20038577701A patent/PA8577701A1/es unknown
- 2003-07-22 PE PE2003000729A patent/PE20040705A1/es not_active Application Discontinuation
- 2003-07-22 AR AR20030102621A patent/AR040651A1/es unknown
- 2003-07-23 GT GT200300155A patent/GT200300155A/es unknown
-
2004
- 2004-12-29 IL IL166038A patent/IL166038A/en not_active IP Right Cessation
-
2005
- 2005-01-06 NO NO20050066A patent/NO20050066L/no not_active Application Discontinuation
- 2005-01-11 ZA ZA2005/00258A patent/ZA200500258B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4381301B2 (ja) | 2009-12-09 |
| IL166038A0 (en) | 2006-01-15 |
| IL166038A (en) | 2010-11-30 |
| CN100357317C (zh) | 2007-12-26 |
| KR20050027257A (ko) | 2005-03-18 |
| CN1671736A (zh) | 2005-09-21 |
| AR040651A1 (es) | 2005-04-13 |
| TW200416225A (en) | 2004-09-01 |
| CA2493534C (en) | 2010-01-26 |
| PA8577701A1 (es) | 2004-02-07 |
| ATE489401T1 (de) | 2010-12-15 |
| HRP20050024A2 (en) | 2006-02-28 |
| US7049415B2 (en) | 2006-05-23 |
| JP2006511455A (ja) | 2006-04-06 |
| PE20040705A1 (es) | 2004-10-14 |
| AU2003257467A1 (en) | 2004-02-23 |
| RU2296769C2 (ru) | 2007-04-10 |
| NO20050066L (no) | 2005-04-22 |
| KR100637981B1 (ko) | 2006-10-23 |
| ZA200500258B (en) | 2006-01-25 |
| ES2354609T3 (es) | 2011-03-16 |
| GT200300155A (es) | 2004-03-15 |
| EP1527088B1 (en) | 2010-11-24 |
| CA2493534A1 (en) | 2004-02-12 |
| AU2003257467B2 (en) | 2008-02-28 |
| MXPA05000797A (es) | 2005-04-19 |
| RU2005105577A (ru) | 2005-10-27 |
| US20040049018A1 (en) | 2004-03-11 |
| EP1527088A1 (en) | 2005-05-04 |
| BR0312889A (pt) | 2005-06-14 |
| DE60335111D1 (de) | 2011-01-05 |
| WO2004013164A1 (en) | 2004-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL166038A (en) | Pegylated t20 polypeptide | |
| PL375218A1 (pl) | Zrekombinowane warianty białka | |
| GB0201679D0 (en) | Polypeptide variants | |
| GB0100196D0 (en) | Peptides | |
| EP1614695A4 (en) | POLYPEPTIDE | |
| GB0218977D0 (en) | Polypeptide | |
| GB0109438D0 (en) | Peptides | |
| IL166037A0 (en) | Pegylated t1249 polypeptide | |
| GB0223193D0 (en) | Polypeptide | |
| GB0202275D0 (en) | Peptide | |
| GB0103517D0 (en) | Polypeptide | |
| GB0208925D0 (en) | Polypeptide | |
| GB0219980D0 (en) | Peptides | |
| EP1477559A4 (en) | NEW POLYPEPTIDE | |
| GB0210746D0 (en) | Peptide | |
| GB0202221D0 (en) | Novel polypeptide | |
| GB0101739D0 (en) | Novel polypeptide | |
| GB0219720D0 (en) | Polypeptide | |
| GB0222181D0 (en) | Polypeptide | |
| GB0203669D0 (en) | Peptides | |
| GB0224896D0 (en) | Peptides | |
| GB0104118D0 (en) | Novel polypeptide | |
| GB0101222D0 (en) | Novel polypeptide | |
| GB0111031D0 (en) | Novel polypeptide | |
| GB0100039D0 (en) | Novel polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |